Dare Bioscience (DARE) Capital Expenditures (2013 - 2025)
Dare Bioscience's Capital Expenditures was $206,641 in Q4 2025, down 63.3% from $562,849 a year earlier but up 18.3% from the prior quarter.
Powered by 
Analysis
Dare Bioscience (DARE) Capital Expenditures (2013 - 2025) Analysis & Trends
For FY2025, Capital Expenditures at Dare Bioscience came in at $385,278, down 32.8% from FY2024.
- Capital Expenditures shows a five-year compound annual growth rate of 85.3% (FY2020 to FY2025).
- In earlier years, Capital Expenditures was $573,046 in FY2024 (-9.0%), $629,430 in FY2023 (+898.0%), $63,069 in FY2022 (+334.2%) and $14,524 in FY2021 (-17.6%).
- Quarterly Capital Expenditures has moved between -$282,325 (Q3 2024) and $607,331 (Q4 2023) over five years.
- Per Business Quant data, DARE's Capital Expenditures in the three quarters before Q4 2025 was $174,702 (Q3 2025), -$153,396 (Q2 2025) and $157,331 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Dare Bioscience | 11.38 Mn | -54.09 Mn | -132,343.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 206,641.00 |
| Sep 30, 2025 | 174,702.00 |
| Jun 30, 2025 | -153,396.00 |
| Mar 31, 2025 | 157,331.00 |
| Dec 31, 2024 | 562,849.00 |
| Sep 30, 2024 | -282,325.00 |
| Jun 30, 2024 | 285,226.00 |
| Mar 31, 2024 | 7,296.00 |
| Dec 31, 2023 | 607,331.00 |
| Sep 30, 2023 | 22,099.00 |
| Dec 31, 2022 | 2,697.00 |
| Sep 30, 2022 | 55,003.00 |
| Jun 30, 2022 | 816.00 |
| Mar 31, 2022 | 4,553.00 |
| Sep 30, 2021 | 14,524.00 |
| Dec 31, 2020 | 2,379.00 |
| Sep 30, 2018 | 3,636.00 |
| Dec 31, 2016 | 36,000.00 |
| Sep 30, 2016 | 27,000.00 |
| Jun 30, 2016 | 113,000.00 |
API Access
Dare Bioscience Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=DARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "DARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=DARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();